The era of easy cures is ending. Bacteria are evolving faster than we can develop new drugs. Superbugs like MRSA kill 700,000 people worldwide each year — and without action, that number could rise to 10 million by 2050. Antimicrobial resistance is one of the greatest threats to human health.
Imagine a hospital where doctors notice that a common antibiotic is no longer curing infections it used to treat easily.
Write down your answers before reading on:
Natural selection in action
Antibiotics
Antimicrobial resistance is a perfect example of natural selection happening in real time. Here is how it works:
This process is accelerated when:
Resistance can also spread between bacteria through horizontal gene transfer — bacteria can share resistance genes directly, even between different species. This makes resistance spread much faster than through reproduction alone.
When bacteria outsmart our drugs
Superbugs are bacteria that have developed resistance to multiple antibiotics. Some of the most dangerous include:
Superbugs are especially dangerous in hospitals, where patients have weakened immune systems and invasive procedures create opportunities for infection.
Why AMR affects everyone
The World Health Organization has declared antimicrobial resistance one of the top ten global public health threats. The consequences are staggering:
AMR is a global problem because resistant bacteria do not respect borders. International travel, food trade, and medical tourism all spread resistant bacteria worldwide. A superbug emerging in one country can quickly become a global threat.
What Australia and the world are doing
Combating AMR requires action across many fronts:
Stewardship: Using antibiotics only when necessary and choosing the right drug, dose, and duration. Australia's National Antimicrobial Resistance Strategy promotes appropriate prescribing.
Infection prevention: Hand hygiene, sanitation, and vaccination reduce infections, reducing the need for antibiotics. Australian hospitals have strict hand hygiene programs.
Surveillance: Tracking resistance patterns helps guide treatment and detect emerging threats. The Australian Group on Antimicrobial Resistance monitors resistance nationally.
Research: Developing new antibiotics, alternative treatments (phage therapy, monoclonal antibodies), and rapid diagnostic tests. Australian researchers at institutions like the University of Queensland are working on new approaches.
One Health: Recognising that human, animal, and environmental health are linked. Antibiotics used in agriculture can create resistant bacteria that affect humans. Australia regulates agricultural antibiotic use more strictly than many countries.
"Antibiotic resistance means the person becomes resistant." No — resistance is a property of bacteria, not people. The bacteria infecting a person evolve to survive antibiotics. The person does not change.
"Superbugs are only a problem in developing countries." No — superbugs are a global problem. MRSA and CRE are significant issues in Australian hospitals. International travel spreads resistant bacteria everywhere.
Healthcare-associated infections: Australian hospitals report thousands of healthcare-associated infections each year, with MRSA among the most concerning. Before strict infection control measures were introduced in the 1990s, MRSA rates in Australian hospitals were rising steadily. Today, hand hygiene compliance programs, patient screening, and isolation protocols have reduced but not eliminated MRSA infections.
Community-acquired MRSA: A new concern is community-acquired MRSA — infections in people with no hospital contact. In remote Indigenous communities, high rates of skin infections combined with antibiotic use have created conditions where resistant strains can emerge and spread. Australian researchers are studying these community strains to inform prevention strategies.
Australian research frontiers: Scientists at the University of Melbourne's Doherty Institute and the University of Queensland are developing new approaches to combat AMR. These include bacteriophage therapy (using viruses that kill bacteria), antimicrobial peptides, and AI-driven drug discovery. Australian researchers also contribute to international collaborations tracking global resistance patterns.
1. How does natural selection lead to antibiotic resistance?
2. MRSA is dangerous because it:
3. Horizontal gene transfer allows bacteria to:
4. Why is developing new antibiotics difficult?
5. The One Health approach to AMR recognises that:
1. Explain the process of natural selection as it applies to antibiotic resistance. Include the roles of mutation, selection pressure, and reproduction. 4 MARKS
2. Describe three factors that have accelerated the development and spread of antimicrobial resistance. For each, explain how it contributes to the problem. 4 MARKS
3. Without new antibiotics, common medical procedures could become life-threatening. Evaluate this statement, considering the role of antibiotics in modern medicine. 4 MARKS
Go back to your Think First answer. Has your understanding changed?
B — Random mutations create natural variation in bacterial populations. When antibiotics are used, they kill susceptible bacteria but allow resistant mutants to survive and multiply. Over time, resistant strains dominate.
B — MRSA (methicillin-resistant Staphylococcus aureus) is dangerous because it has developed resistance to many commonly used antibiotics, making infections difficult to treat.
B — Horizontal gene transfer allows bacteria to share genetic material, including resistance genes, directly with other bacteria — even different species. This dramatically speeds up the spread of resistance.
B — Developing new antibiotics is scientifically difficult because bacteria have evolved to resist most known mechanisms. It is also economically unprofitable because antibiotics are used for short courses, unlike profitable chronic medications.
B — The One Health approach recognises that human, animal, and environmental health are interconnected, and that antibiotic use in one area affects resistance in others.
Model answer: Antibiotic resistance evolves through natural selection in the following way: (1) Mutation — random genetic mutations occur during bacterial reproduction. By chance, some mutations make bacteria slightly less susceptible to an antibiotic. (2) Selection pressure — when antibiotics are used, they create an environment where susceptible bacteria cannot survive. The antibiotic acts as a selective force. (3) Survival and reproduction — resistant bacteria survive the antibiotic exposure while susceptible bacteria die. The surviving resistant bacteria multiply, passing their resistance genes to offspring. (4) Population change — over repeated antibiotic exposure, resistant bacteria become the dominant population. Eventually, the antibiotic becomes ineffective against most bacteria in that population.
Model answer: Three factors accelerating antimicrobial resistance are: (1) Overuse in human medicine: Antibiotics are often prescribed unnecessarily for viral infections or used too broadly when narrow-spectrum alternatives would suffice. This creates constant selection pressure, favouring resistant strains. (2) Use in agriculture: Antibiotics used to promote growth or prevent disease in livestock create reservoirs of resistant bacteria. These bacteria can spread to humans through food, water, or direct contact. (3) Incomplete antibiotic courses: When patients stop taking antibiotics early, the most susceptible bacteria are killed but the strongest survivors remain. These survivors multiply, and their offspring may be resistant. Additionally, international travel spreads resistant bacteria globally, and poor sanitation in some regions allows resistant strains to circulate widely.
Model answer: This statement is accurate and concerning. Antibiotics are essential for modern medicine in ways that are often invisible. After surgery, antibiotics prevent wound infections that could otherwise be fatal. Chemotherapy suppresses the immune system, leaving patients vulnerable to infections that antibiotics control. Organ transplants require immunosuppressants, making recipients dependent on antibiotics to survive. Caesarean sections, joint replacements, and dialysis all carry infection risks managed by antibiotics. Without effective antibiotics, the risk of these procedures would increase dramatically, potentially making some too dangerous to perform. This would represent a regression to the pre-antibiotic era when minor injuries and common infections were often fatal. The solution requires not just new antibiotics but also better stewardship, infection prevention, and investment in alternative treatments like phage therapy and vaccines.
Evolve bacteria to survive antibiotics! Understand how resistance develops and explore strategies to slow its spread in this evolutionary biology game.
Tick when you have finished all activities and checked your answers.